Zurcher Kantonalbank (Zurich Cantonalbank) - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$433,962
-3.9%
9,436
+20.1%
0.00%0.0%
Q2 2023$451,369
+76.9%
7,854
+15.4%
0.00%
+100.0%
Q1 2023$255,113
+16.3%
6,803
-13.1%
0.00%0.0%
Q4 2022$219,425
+20.6%
7,831
+21.2%
0.00%0.0%
Q3 2022$182,000
-19.1%
6,4620.0%0.00%0.0%
Q2 2022$225,000
+16.0%
6,462
+19.6%
0.00%0.0%
Q1 2022$194,000
+24.4%
5,401
-19.5%
0.00%0.0%
Q4 2021$156,000
+132.8%
6,710
+89.1%
0.00%
Q3 2021$67,000
-6.9%
3,5490.0%0.00%
Q2 2021$72,000
-26.5%
3,549
-33.5%
0.00%
-100.0%
Q1 2021$98,000
-8.4%
5,3400.0%0.00%0.0%
Q4 2020$107,000
+7.0%
5,3400.0%0.00%0.0%
Q3 2020$100,000
-16.7%
5,3400.0%0.00%0.0%
Q2 2020$120,000
+233.3%
5,340
+121.5%
0.00%
Q1 2020$36,000
-23.4%
2,4110.0%0.00%
Q4 2019$47,000
-2.1%
2,4110.0%0.00%
Q3 2019$48,000
-5.9%
2,4110.0%0.00%
Q2 2019$51,000
+4.1%
2,4110.0%0.00%
Q1 2019$49,000
-22.2%
2,411
-24.4%
0.00%
-100.0%
Q4 2018$63,000
+3.3%
3,1880.0%0.00%0.0%
Q3 2018$61,000
+24.5%
3,1880.0%0.00%
Q2 2018$49,000
-18.3%
3,1880.0%0.00%
-100.0%
Q1 2018$60,000
-1.6%
3,1880.0%0.00%0.0%
Q4 2017$61,000
+64.9%
3,188
+53.0%
0.00%
Q3 2017$37,0000.0%2,0830.0%0.00%
Q2 2017$37,000
+23.3%
2,0830.0%0.00%
Q1 2017$30,000
-21.1%
2,0830.0%0.00%
Q4 2016$38,000
-5.0%
2,0830.0%0.00%
Q3 2016$40,000
+42.9%
2,083
+19.2%
0.00%
Q2 2016$28,000
+33.3%
1,7480.0%0.00%
Q1 2016$21,000
-16.0%
1,7480.0%0.00%
Q4 2015$25,000
+316.7%
1,748
+268.8%
0.00%
Q3 2015$6,0004740.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders